Suppr超能文献

通过功能扩散加权成像评估放射造影剂诱导的肾病

Evaluation of Radiographic Contrast-Induced Nephropathy by Functional Diffusion Weighted Imaging.

作者信息

Thiel Thomas Andreas, Schweitzer Julian, Xia Taogetu, Bechler Eric, Valentin Birte, Steuwe Andrea, Boege Friedrich, Westenfeld Ralf, Wittsack Hans-Jörg, Ljimani Alexandra

机构信息

Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich Heine University Dusseldorf, D-40225 Düsseldorf, Germany.

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich Heine University Düsseldorf, D-40225 Düsseldorf, Germany.

出版信息

J Clin Med. 2021 Oct 1;10(19):4573. doi: 10.3390/jcm10194573.

Abstract

Contrast-induced nephropathy (CIN) resembles an important complication of radiographic contrast medium (XCM) displayed by a rise in creatinine levels 48-72 h after XCM administration. The purpose of the current study was to evaluate microstructural renal changes due to CIN in high-risk patients by diffusion weighted (DWI) and diffusion tensor imaging (DTI). Fifteen patients (five CIN and ten non-CIN) scheduled for cardiological intervention were included in the study. All patients were investigated pre- and post-intervention on a clinical 3T scanner. After anatomical imaging, renal DWI was performed by a paracoronal echo-planar-imaging sequence. Renal clinical routine serum parameters and advanced urinary injury markers were determined to monitor renal function. We observed a drop in cortical and medullar apparent diffusion coefficient (ADC) and fractional anisotropy (FA) before and after XCM administration in the CIN group. In contrast, the non-CIN group differed only in medullary ADC. The decrease of ADC and FA was apparent even before serum parameters of the kidney changed. In conclusion, DWI/DTI may be a useful tool for monitoring high-risk CIN patients as part of multi-modality based clinical protocol. Further studies, including advanced analysis of the diffusion signal, may improve the identification of patients at risk for CIN.

摘要

对比剂肾病(CIN)是影像学对比剂(XCM)的一种重要并发症,表现为在使用XCM后48 - 72小时肌酐水平升高。本研究的目的是通过扩散加权成像(DWI)和扩散张量成像(DTI)评估高危患者中CIN所致的肾脏微观结构变化。本研究纳入了15例计划接受心脏介入治疗的患者(5例CIN患者和10例非CIN患者)。所有患者在介入治疗前后均在临床3T扫描仪上进行检查。在进行解剖成像后,通过冠状位回波平面成像序列进行肾脏DWI检查。测定肾脏临床常规血清参数和先进的尿损伤标志物以监测肾功能。我们观察到CIN组在使用XCM前后皮质和髓质的表观扩散系数(ADC)和分数各向异性(FA)均下降。相比之下,非CIN组仅在髓质ADC方面有所不同。即使在肾脏血清参数改变之前,ADC和FA的下降就已很明显。总之,DWI/DTI可能是作为基于多模态的临床方案的一部分来监测高危CIN患者的有用工具。包括对扩散信号进行深入分析在内的进一步研究,可能会改善对CIN高危患者的识别。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f292/8509538/a03599fcf3a3/jcm-10-04573-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验